These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8483022)

  • 1. Are there differences in the renal effects of calcium antagonists?
    Leonetti G; Rappelli A
    J Hypertens Suppl; 1993 Mar; 11(1):S45-8. PubMed ID: 8483022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
    Leonetti G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of calcium antagonists in hypertensive patients.
    Leonetti G; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S535-9. PubMed ID: 2856781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dihydropyridine calcium antagonists in hypertensive patients with impaired renal function.
    Hansson LH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S36-9; discussion S59-62. PubMed ID: 2483570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of felodipine in hypertension.
    Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A
    Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients.
    Takabatake T; Ohta H; Sasaki T; Satoh S; Ohta K; Ise T; Kobayashi K
    Eur J Clin Pharmacol; 1993; 45(4):321-5. PubMed ID: 8299663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium antagonists on the hypertensive kidney.
    Reams GP; Bauer JH
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1331-5. PubMed ID: 2278868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilators, antihypertensive therapy and the kidney.
    Hollenberg NK
    Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.